secwatch.observer — SEC 8-K summary
======================================

Issuer:     STERIS plc (STE)
CIK:        0001757898
Form:       8-K
Filed at:   2023-05-03T23:59:59+00:00
Accession:  0001193125-23-134570
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

STERIS appoints Esther Alegria to Board of Directors effective May 3, 2023
--------------------------------------------------------------------------

- Board size increased to ten members; Dr. Alegria, age 64, appointed immediately.
- She is Founder & CEO of APIE Therapeutics; previously SVP Global Manufacturing at Biogen.
- Prorated director fee of $74,220 payable in restricted stock units for remainder of 2022-23 term.
- Also serves on AVID Bioservices (NASDAQ: CDMO) board and its audit and governance committees.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1757898/000119312523134570/0001193125-23-134570-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1757898/000119312523134570/d287600d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-134570

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer